Veracyte

Photo: MIKI Yoshihito from Sapporo City,Hokkaido., JAPAN / Wikimedia Commons, CC BY 2.0

Veracyte buys bladder cancer urine test maker Convergent Genomics for up to $180 million

The diagnostics company paid $150 million in cash upfront for UroAmp, a test that reads tumour DNA in urine, with $30 million more tied to winning reimbursement.